Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Other Non-Current Assets (2019 - 2026)

TELA Bio has reported Other Non-Current Assets over the past 4 years, most recently at $250000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 89.02% year-over-year to $250000.0; the TTM value through Dec 2025 reached $250000.0, down 89.02%, while the annual FY2025 figure was $250000.0, 89.02% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $250000.0 at TELA Bio, roughly flat from $250000.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $2.3 million in Q4 2024 and troughed at $250000.0 in Q3 2025.
  • A 3-year average of $581333.3 and a median of $265000.0 in 2023 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: surged 758.87% in 2024 and later plummeted 89.02% in 2025.
  • Year by year, Other Non-Current Assets stood at $265000.0 in 2023, then surged by 758.87% to $2.3 million in 2024, then plummeted by 89.02% to $250000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for TELA at $250000.0 in Q4 2025, $250000.0 in Q3 2025, and $1.1 million in Q2 2025.